Muhammad Shariq Usman, Deepak L Bhatt, Ishaque Hameed, Stefan D. Anker, Alice Y Y Cheng, Adrian F Hernandez, William Schuyler Jones, Muhammad Shahzeb Khan, Mark C Petrie, Jacob A Udell, Tim Friede, J. Butler
{"title":"SGLT2 抑制剂对心血管代谢疾病谱中心衰预后和心血管死亡的影响:系统回顾和荟萃分析","authors":"Muhammad Shariq Usman, Deepak L Bhatt, Ishaque Hameed, Stefan D. Anker, Alice Y Y Cheng, Adrian F Hernandez, William Schuyler Jones, Muhammad Shahzeb Khan, Mark C Petrie, Jacob A Udell, Tim Friede, J. Butler","doi":"10.1016/s2213-8587(24)00102-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517557,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"298 2‐3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis\",\"authors\":\"Muhammad Shariq Usman, Deepak L Bhatt, Ishaque Hameed, Stefan D. Anker, Alice Y Y Cheng, Adrian F Hernandez, William Schuyler Jones, Muhammad Shahzeb Khan, Mark C Petrie, Jacob A Udell, Tim Friede, J. Butler\",\"doi\":\"10.1016/s2213-8587(24)00102-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517557,\"journal\":{\"name\":\"The Lancet Diabetes & Endocrinology\",\"volume\":\"298 2‐3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Diabetes & Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2213-8587(24)00102-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Diabetes & Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2213-8587(24)00102-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis